Showing results (21-30 of 117) with videos related to
Sort By:
Pageof 12
Bone Marrow Transplantation|August 1, 1993
Unrelated donor BMT for Wiskott-Aldrich syndromeC Lenarsky, K Weinberg, D B Kohn, et al.Seminars in Hematology|November 4, 1998
Hematopoietic stem cell transplantation for primary lymphoid immunodeficienciesN Kapoor, G Crooks, D B Kohn, et al.Blood|July 1, 1995
Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cellsJ A Nolta, E M Smogorzewska, D B KohnPhysiological Chemistry and Physics|January 1, 1979
The role of inert particles in malignant transformations: a hypothesis of carcinogenesisB Ecanow, B H Gold, D B Kohn, et al.The American Journal of Pediatric Hematology/Oncology|January 1, 1987
Immunologic studies of lymph node lymphocytes in the generalized lymphadenopathy syndromeD B Kohn, M E Trigg, W Borcherding, et al.Antisense & Nucleic Acid Drug Development|January 1, 1996
Expression of hammerhead ribozymes by retroviral vectors to inhibit HIV-1 replication: comparison of RNA levels and viral inhibitionC Zhou, I Bahner, J J Rossi, et al.Hematology/Oncology Clinics of North America|June 1, 1990
Bone marrow transplantation for genetic diseasesC Lenarsky, D B Kohn, K I Weinberg, et al.Pharmacology & Therapeutics|January 1, 1991
The potential use of catalytic RNAs in therapy of HIV infection and other diseasesJ J Rossi, E M Cantin, N Sarver, et al.The EMBO Journal|April 1, 1988
Expression of acidic fibroblast growth factor cDNA confers growth advantage and tumorigenesis to Swiss 3T3 cellsM Jaye, R M Lyall, R Mudd, et al.The American Journal of Pediatric Hematology/Oncology|May 1, 1993
Expression of coagulation factor IX (Christmas factor) in human hepatoma (HepG2) cell cultures after retroviral vector-mediated transferE M Gordon, H Tang, R L Salazar, et al.Pageof 12